SCHEMBL166227

SCHEMBL166227

C=Cc1cccc(S(=O)(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.59
TSHR P16473 4/20 0.52
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.45
MCL1 Q07820 2/20 0.42
NAPRT Q6XQN6 1/20 0.38
PTGS2 P35354 1/20 0.37
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
LMNA P02545 1/20 0.35
HDAC3 O15379 2/20 0.35
HDAC4 P56524 2/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC7 Q8WUI4 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC10 Q969S8 2/20 0.35
HDAC11 Q96DB2 2/20 0.35
HDAC8 Q9BY41 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362912 1.00 TDP1 (0.59) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL313977 0.98 TDP1 (0.57) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
Ammonia Solution, Strong SCHEMBL2027060 0.98 TDP1 (0.57) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL331712 0.98 TDP1 (0.57) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL2119493 0.98 TDP1 (0.57) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
Ammonia Solution, Strong SCHEMBL2118045 0.98 TDP1 (0.57) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL7520300 0.84 TDP1 (0.54) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL6254180 0.83 LMNA (0.48) TDP1TSHRALDH1A1SMN1; SMN2TP53
SCHEMBL30541813 0.82 TDP1 (0.41) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2
SCHEMBL1373920 0.82 ALDH1A1 (0.53) TDP1TSHRALDH1A1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115073628-B Metallocene catalyst system loaded by porous organic polymer carrier and preparation method and application thereof 中国石油天然气股份有限公司 2023-09-26 CN claimed
CN-115073629-B Supported metallocene catalyst system and preparation method and application thereof 中国石油天然气股份有限公司 2023-09-26 CN claimed
US-11760672-B2 Antiscale dispersant composition and use thereof ECOLAB USA INC. (US) 2023-09-19 US claimed
CN-115073628-A Metallocene catalyst system loaded by porous organic polymer carrier and preparation method and application thereof 中国石油天然气股份有限公司 2022-09-20 CN claimed
CN-115073629-A Supported metallocene catalyst system and preparation method and application thereof 中国石油天然气股份有限公司 2022-09-20 CN claimed
US-20200207671-A1 PROCESS FOR PRODUCING AN AQUEOUS DISPERSION AND REDISPERSIBLE DISPERSION POWDER PRODUCED THEREFROM BASF SE (DE) 2020-07-02 US claimed
CN-110831913-A Method for producing aqueous dispersions and redispersible dispersion powders produced therefrom 巴斯夫欧洲公司 2020-02-21 CN claimed
US-10138307-B2 Antimicrobial polymer Fachhochschule Münster (DE) 2018-11-27 US claimed
US-20180244553-A1 ANTISCALE DISPERSANT COMPOSITION AND USE THEREOF ECOLAB USA INC. 2018-08-30 US claimed
EP-2951216-B1 ANTI-MICROBIAL POLYMER FACHHOCHSCHULE MUENSTER (DE) 2018-07-18 EP claimed
US-20150368380-A1 ANTIMICROBIAL POLYMER Fachhochschule Münster (DE) 2015-12-24 US claimed
EP-2951216-A1 ANTI-MICROBIAL POLYMER Fachhochschule Münster (DE) 2015-12-09 EP claimed
EP-1745110-B1 METHOD FOR PRODUCTION OF PROTON-CONDUCTING CLAY PARTICLES AND COMPOSITE MATERIAL COMPRISING SAID PARTICLES COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2015-07-29 EP claimed
EP-2157064-B1 Composition for ceramic extrusion-molded body and method for manufacturing a ceramic extrusion-molded body SHINETSU CHEMICAL CO (JP) 2014-08-20 EP claimed
WO-2014118339-A1 ANTI-MICROBIAL POLYMER Fachhochschule Münster (DE) 2014-08-07 WO claimed
US-8739977-B2 Composite semipermeable membrane and method for producing the same TORAY INDUSTRIES, INC. (JP) 2014-06-03 US claimed
US-8562728-B2 Process for preparing proton-conducting clay particles and composite material comprising such particles COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2013-10-22 US claimed
US-8501369-B2 Composite for fuel cell membrane based on organomodified inorganic particles and method for preparing same COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2013-08-06 US claimed
US-20100196786-A1 Composite for Fuel Cell Membrane Based on Organomodified Inorganic Particles and Method for Preparing Same COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2010-08-05 US claimed
US-20080102339-A1 Process for Preparing Proton-Conducting Clay Particles and Composite Material Comprising Such Particles COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-05-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10138307-B2 Antimicrobial polymer PUF60, PARG, DPM1 TDP1 3198/4885TSHR 4853/4885ALDH1A1 3068/4885
US-20150368380-A1 ANTIMICROBIAL POLYMER PUF60, PARG, DPM1 TDP1 3198/4885TSHR 4853/4885ALDH1A1 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.